(PharmaNewsWire.Com, February 19, 2019 ) Global API Manufacturers of Marketed Products for B-Cell Lymphomas Coverage of API manufacturers for B-Cell Lymphomas marketed products spanning across United States, Europe, China and India. The manufacturers' details include manufacturers' name along with their location.
Emerging Phase III products for B-Cell Lymphomas This report provides a comprehensive understanding of the emerging Phase III therapies for B-Cell Lymphomas which can turn out to be future prospective competitors for the marketed products. It will also put light on the current market trends. Their forecasted global sales are also provided till 2020.
Methodology The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Publisher team of industry experts. Secondary information and data has been collected from various printable and non-printable sources like search engines, news websites, government websites, trade journals, white papers, magazines, trade associations, books, industry portals, industry associations and available databases.
Scope -A review of the marketed products for B-Cell Lymphomas including their description, route of synthesis, regulatory milestones, forecasted sales estimates till 2020 and API manufacturer details. -Patent information coverage of the marketed products including the patent number, holder, grant and patent expiry details -API manufacturers for the marketed products with location details -Emerging Phase III product profiles for B-Cell Lymphomas including product description, developmental activities, licensors & collaborators and chemical information
Table 1: List of Marketed and Emerging Products Table 2: Drug Product Details, United States Table 3: Drug Product Details, Europe Table 4: Drug, Historical Global Sales till 2017 (in million USD) Table 5: Drug, Forecasted Global Sales from 2018-2020 (in million USD) Table 6: API Manufacturers Region wise Table 7: API Manufacturers for United States Table 8: API Manufacturers for Europe Table 9: API Manufacturers for China Table 10: API Manufacturers for India Table 11: Patent Details Table 12: Emerging Therapies (Phase III) Table 13: Drug, Forecasted Global Sales from 2018-2020 (in million USD)
List of Figures
Figure 1: Comparative Analysis of Marketed and Emerging Products Figure 2: Drug, Historical Global Sales till 2017 (in million USD) Figure 3: Drug, Forecasted Global Sales from 2018-2020 (in million USD) Figure 4: Patent Details Figure 5: API Manufacturers Region wise Figure 6: Drug, Forecasted Global Sales from 2018-2020 (in million USD)
Reasons to Buy -API intelligence for marketed drugs for the indication and gaining insights of API manufacturers -Evaluate the marketing status and patent details of products to exploit opportunities for generic drug development -Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to the indication -Establish a comprehensive understanding of the emerging Phase III products which can be future competitors in this space
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
